NYSEArca - Nasdaq Real Time Price USD

Invesco Biotechnology & Genome ETF (PBE)

60.82 -0.33 (-0.53%)
As of 3:04 PM EDT. Market Open.

Performance Overview: PBE

Trailing returns as of 4/23/2024. Category is Health.

YTD Return

PBE
7.09%
Category
6.33%

1-Year Return

PBE
3.97%
Category
11.04%

3-Year Return

PBE
7.18%
Category
0.38%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
PBE
Category
YTD
-1.74%
6.33%
1-Month
-1.20%
1.19%
3-Month
-1.74%
6.33%
1-Year
3.07%
11.04%
3-Year
-4.27%
-0.38%
5-Year
3.25%
7.51%
10-Year
4.79%
9.04%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
PBE
Category
2023
3.71%
3.22%
2022
-10.83%
-15.16%
2021
1.54%
6.88%
2020
25.66%
27.63%
2019
18.65%
26.23%
2018
-0.19%
-0.40%
2017
22.28%
24.31%
2016
-22.90%
-10.60%

2015
1.73%
8.05%
2014
36.34%
27.25%
2013
62.24%
48.17%
2012
13.84%
21.55%
2011
-8.36%
7.66%
2010
31.47%
8.38%
2009
21.92%
22.48%
2008
-26.75%
-23.43%
2007
6.06%
9.27%
2006
1.61%
4.27%

ETF Summary

The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

ETF Overview

Category Health
Fund Family Invesco
Net Assets 245.86M
YTD Daily Total Return -7.09%
Yield 0.06%
Legal Type Exchange Traded Fund

Related Tickers